Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Dividends payables came in at $198000.0 in Q1 2026, down 28.0% on a QoQ basis from $275000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 2 years of Dividends payables data on file, last reported at $198000.0 in Q1 2026.
- Quarterly Dividends payables changed N/A year-over-year to $198000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198000.0 (changed N/A YoY) and the FY2025 annual result came in at $275000.0, changed N/A from the prior year.
- Dividends payables slipped to $198000.0 in Q1 2026, from $275000.0 in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $275000.0 in Q4 2025 to a low of $198000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 264,000.00 |
| Mar 31, 2026 | 198,000.00 |
| Dec 31, 2025 | 275,000.00 |